Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cardiomyopathy
cardiomyopathy
Alnylam’s vutrisiran aces ATTR cardiomyopathy readout
Pharmaphorum
Mon, 06/24/24 - 10:52 am
Alnylam
RNAi
vutrisiran
ATTR
cardiomyopathy
AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Fierce Biotech
Fri, 02/2/24 - 11:53 am
AstraZeneca
Pfizer
acoramidis
Japan
clinical trials
cardiomyopathy
ATTR-CM
Cytokinetics' heart failure drug improves exercise capacity, sending shares soaring in long-awaited win
Fierce Biotech
Wed, 12/27/23 - 11:06 pm
Cytokinetics
cardiomyopathy
aficamten
heart failure
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
Clinical Trials Arena
Mon, 04/24/23 - 11:23 am
Cytokinetics
clinical trials
ALS
reldesemtiv
cardiomyopathy
aficamten
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
Yahoo/PR Newswire
Sun, 05/3/20 - 07:53 pm
Biomarin
DiNAQOR
gene therapy
cardiomyopathy